Biotricity CEO, Waqaas Al-Siddiq, on New Heart Health Innovations & the Future of Cardiac Care

Biotricity is transforming the healthcare market by bridging the gap in remote monitoring and chronic care management with a focus on cardiology. Physicians and patients trust Biotricity's unparalleled standard for preventive and personal care, including diagnostic and post-diagnostic solutions for chronic conditions. The company develops comprehensive remote health monitoring solutions for the medical and consumer markets. Visit btcyinfo.com to learn more. RedChip Companies, Inc. research reports, company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RedChip reports, company profiles, or other investor relations materials and presentations are subject to change. RedChip Companies and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.   Biotricity (BTCY) is a client of RedChip Companies. BTCY agreed to pay RedChip Companies a $7,500 monthly cash fee, beginning in February 2024, and 60,000 warrants, with an exercise price of $1.40 and three-year term, for 6 months of RedChip investor awareness services. BTCY also agreed to pay RedChip a one-time fifty-thousand dollar fee for a 10-day national TV ad campaign aired weekdays from April 8 through April 19, 2024 and a forty-five thousand dollar fee for a 10-day national TV ad campaign aired weekdays from June 24 through July 8, 2024.   For full disclosure, visit RedChip.com/disclosures.